908 DEVICES INC. Amortization of Intangible Assets
908 DEVICES INC. (MASS) reported Amortization of Intangible Assets of $928.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-11
- 908 DEVICES INC. amortization of intangible assets for the quarter ending 2026-06-30 was $928.00K, a 30.15% increase year-over-year.
- 908 DEVICES INC. amortization of intangible assets for the quarter ending 2026-03-31 was $733.00K, a 2.81% increase year-over-year.
- 908 DEVICES INC. amortization of intangible assets for the quarter ending 2025-12-31 was $732.00K, a 2.81% increase year-over-year.
- 908 DEVICES INC. amortization of intangible assets for the quarter ending 2025-09-30 was $732.00K, a 2.66% increase year-over-year.
- 908 DEVICES INC. amortization of intangible assets for fiscal 2025 was $2.89M, a 52.11% increase from fiscal 2024.
- 908 DEVICES INC. amortization of intangible assets for fiscal 2024 was $1.90M, a 116.65% increase from fiscal 2023.
- 908 DEVICES INC. amortization of intangible assets for fiscal 2023 was $877.00K, a 155.69% increase from fiscal 2022.
- 908 DEVICES INC. amortization of intangible assets for fiscal 2022 was $343.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $928.00K 10-Q · filed 2026-08-11 | $1.66M 10-Q · filed 2026-08-11 | $2.39M derived: sum of 3 quarters · filed 2026-08-11 | $3.13M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $733.00K 10-Q · filed 2026-05-06 | $1.47M derived: sum of 2 quarters · filed 2026-05-06 | $2.20M derived: sum of 3 quarters · filed 2026-05-06 | $2.91M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.46M derived: sum of 2 quarters · filed 2026-03-09 | $2.18M derived: sum of 3 quarters · filed 2026-08-11 | $2.89M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $732.00K 10-Q · filed 2025-11-10 | $1.45M derived: sum of 2 quarters · filed 2026-08-11 | $2.16M 10-Q · filed 2025-11-10 | $2.87M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $713.00K 10-Q · filed 2026-08-11 | $1.43M 10-Q · filed 2026-08-11 | $2.14M derived: sum of 3 quarters · filed 2026-08-11 | $2.85M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $713.00K 10-Q · filed 2026-05-06 | $1.43M derived: sum of 2 quarters · filed 2026-05-06 | $2.14M derived: sum of 3 quarters · filed 2026-05-06 | $2.61M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.43M derived: sum of 2 quarters · filed 2026-03-09 | $1.90M derived: sum of 3 quarters · filed 2026-03-09 | $1.90M 10-K · filed 2026-03-09 | $2.75M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $713.00K 10-Q · filed 2025-11-10 | $930.00K 10-Q · filed 2024-11-12 | $1.19M derived: sum of 2 quarters · filed 2025-11-10 | $1.19M 10-Q · filed 2025-11-10 | $1.84M 10-Q · filed 2024-11-12 | $1.63M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $475.00K 10-Q · filed 2025-08-05 | $693.00K 10-Q · filed 2024-08-06 | $475.00K 10-Q · filed 2025-08-05 | $913.00K 10-Q · filed 2024-08-06 | $914.00K derived: sum of 3 quarters · filed 2025-08-05 | $1.14M derived: sum of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | $220.00K 10-Q · filed 2024-05-03 | $439.00K derived: sum of 2 quarters · filed 2025-03-07 | $660.00K derived: sum of 3 quarters · filed 2025-03-07 | $879.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $440.00K derived: sum of 2 quarters · filed 2025-03-07 | $659.00K derived: sum of 3 quarters · filed 2025-03-07 | $877.00K 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $221.00K 10-Q · filed 2024-11-12 | $440.00K derived: sum of 2 quarters · filed 2024-11-12 | $658.00K 10-Q · filed 2024-11-12 | $866.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $219.00K 10-Q · filed 2024-08-06 | $437.00K 10-Q · filed 2024-08-06 | $645.00K derived: sum of 3 quarters · filed 2024-08-06 | $780.00K derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $218.00K 10-Q · filed 2024-05-03 | $426.00K derived: sum of 2 quarters · filed 2024-05-03 | $561.00K derived: sum of 3 quarters · filed 2024-05-03 | |||||
| 2022-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $343.00K derived: sum of 2 quarters · filed 2024-03-08 | $343.00K 10-K · filed 2024-03-08 | |||||
| 2022-09-30 | $135.00K 10-Q · filed 2023-11-07 | $135.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |